Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;29(4):2626-2627.
doi: 10.1245/s10434-021-11120-9. Epub 2022 Jan 3.

ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy

Pedro Antonio Cascales Campos  1 , Alida González Gil  2
Affiliations
Comment

ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy

Pedro Antonio Cascales Campos et al. Ann Surg Oncol. 2022 Apr.
No abstract available

PubMed Disclaimer

Comment on

  • Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
    van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS. van Driel WJ, et al. N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. N Engl J Med. 2018. PMID: 29342393 Clinical Trial.

References

    1. Armstrong DK, Bundy B, Wenzel L, et al. Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34-43.
    1. Cascales Campos PA, González Gil A, Gil Gómez E. Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11087-7
    1. van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230–40. - DOI
    1. Zivanovic O, Chi DS, Zhou Q, et al. Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: an MSK Team Ovary Phase II study. J Clin Oncol. 2021;39:2594–604. - DOI
    1. Koole S, van Stein R, Sikorska K, et al. OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Int J Gynecol Cancer. 2020;30:888-92.

LinkOut - more resources